Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer with Different HER2 Expression Patterns

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Trastuzumab Deruxtecan

The patients received Trastuzumab Deruxtecan at a dose of 5.4 mg/kg every 3 weeks until disease progression or unacceptable adverse effects occurred.

Trial Locations (23)

410013

RECRUITING

Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

519000

RECRUITING

The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai

Unknown

RECRUITING

Fujian Cancer Hospital, Fujian Medical University, Fuzhou

RECRUITING

The 10th Affiliated Hospital of Southern Medical University, Dongguan

RECRUITING

The First People's Hospital of Foshan, Foshan

RECRUITING

The Sixth Affiliated Hospital, School of Medicine, South China University of Technology., Foshan

RECRUITING

Guangdong Provincial Hospital of Chinese Medicine, Guangzhou

RECRUITING

The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou

RECRUITING

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

RECRUITING

The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou

RECRUITING

Yuebei People's Hospital of Shantou University, Shaoguan

RECRUITING

National Cancer Center Shenzhen Hospital, Shenzhen

RECRUITING

Shenzhen People's Hospital, Shenzhen

RECRUITING

Zhongshan City People's Hospital, Zhongshan

RECRUITING

Changde Hospital, Xiangya School of Medicine, Central South University, Changde

RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

RECRUITING

The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang

RECRUITING

Affiliated Cancer Hospital of Inner Mongolia Medical University, Hohhot

RECRUITING

Xinhua Hospital Afliated to Shanghai Jiaotong University, Shanghai

RECRUITING

The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

RECRUITING

Cancer Hospital of Shantou University Medical College

RECRUITING

The Affiliated Panyu Central Hospital, Guangzhou Medical University

All Listed Sponsors
lead

Sun Yat-sen University

OTHER